OTCMKTS:TRXDW

TransEnterix (TRXDW) Stock Price, News & Analysis

$0.0011
0.00 (0.00%)
(As of 05/15/2024 ET)
Today's Range
$0.0011
$0.0011
50-Day Range
N/A
52-Week Range
$0.0011
$0.0011
Volume
N/A
Average Volume
3,440 shs
Market Capitalization
$157,054.70
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
TRXDW stock logo

About TransEnterix Stock (OTCMKTS:TRXDW)

TransEnterix, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery. The company offers Senhance System, a multi-port robotic surgery system, which allows up to four arms to control robotic instruments and a camera in Europe. It also develops SurgiBot System, a single-port system robotically enhanced laparoscopic surgical platform.. TransEnterix, Inc. is headquartered in Morrisville, North Carolina.

TRXDW Stock Price History

TRXDW Stock News Headlines

Life Science Partners L P Synergy's Net Worth
Asensus Surgical Inc (ASXC)
TransEnterix, Inc. (TRXDW)
Surgical Robots Global Market Report 2023
Asensus Surgical (NYSEMKT: ASXC)
ASXC Asensus Surgical, Inc.
Here's Why TransEnterix Rallied 47% in 2017
See More Headlines
Receive TRXDW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TransEnterix and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/05/2020
Today
5/15/2024

Industry, Sector and Symbol

Sector
Medical
Industry
N/A
Sub-Industry
N/A
Current Symbol
OTCMKTS:TRXDW
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-154,200,000.00
Net Margins
-2,149.15%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$8.53 million
Cash Flow
$0.00 per share
Book Value
$2.68 per share

Miscellaneous

Free Float
N/A
Market Cap
$157,054.70
Optionable
Not Optionable
Beta
2.56
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Mr. Todd M. Pope (Age 53)
    CEO, Pres & Director
  • Mr. Joseph P. Slattery (Age 53)
    Exec. VP, CFO & Principal Accounting Officer
  • Mr. Anthony Fernando (Age 46)
    COO, CTO & Exec. VP
  • Mr. Joshua B. Weingard (Age 45)
    Chief Legal Officer & Sec.
  • Dr. Stephanie M. Fitts Ph.D. (Age 52)
    VP of RA/QA, Clinical and Compliance

TRXDW Stock Analysis - Frequently Asked Questions

How have TRXDW shares performed in 2024?

TransEnterix's stock was trading at $0.05 on January 1st, 2024. Since then, TRXDW shares have decreased by 97.8% and is now trading at $0.0011.
View the best growth stocks for 2024 here
.

How were TransEnterix's earnings last quarter?

TransEnterix, Inc. (OTCMKTS:TRXDW) released its quarterly earnings data on Thursday, November, 5th. The medical instruments supplier reported ($0.12) EPS for the quarter, beating the consensus estimate of ($0.23) by $0.11. The medical instruments supplier earned $0.81 million during the quarter, compared to the consensus estimate of $0.73 million. TransEnterix had a negative trailing twelve-month return on equity of 83.74% and a negative net margin of 2,149.15%.

How do I buy shares of TransEnterix?

Shares of TRXDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:TRXDW) was last updated on 5/15/2024 by MarketBeat.com Staff

From Our Partners